<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR88914-0073 </DOCNO><DOCID>fr.9-14-88.f2.A1072</DOCID><TEXT><ITAG tagnum="94"><ITAG tagnum="69"><ITAG tagnum="50">DEPARTMENT OF HEALTH AND HUMAN SERVICES</ITAG><ITAG tagnum="18">Food and Drug Administration</ITAG><ITAG tagnum="41">[Docket No. 87D-0413]</ITAG><ITAG tagnum="56">Policy And Procedures Guide For Labeling of Animal Drugs That MayBe Human Carcinogens</ITAG><ITAG tagnum="10"><T2>agency:</T2> Food and Drug Administration. </ITAG><ITAG tagnum="10"><T2>action:</T2> Notice. </ITAG><ITAG tagnum="10"><T2>summary:</T2> The Food and Drug Administration (FDA) is announcingthe availability of a labeling guide prepared by FDA's Center for VeterinaryMedicine (CVM) for reviewers of new animal drug applications (NADA's).CVM Staff Manual Guide 1240.3140 concerns a statement that may be calledfor on the labeling of carcinogenic new animal drugs. </ITAG><ITAG tagnum="10"><T2>address:</T2> Requests for single copies of CVM Staff Manual Guide1240.3140 may be submitted to the Dockets Management Branch (HFA-305),Food and Drug Administration, Rm. 4-62, 5600 Fishers Lane, Rockville, MD20857. (Send two self-addressed adhesive lables to assist the Branch inprocessing your request.) </ITAG><ITAG tagnum="10"><T2>for further information contact:</T2> Bob G. Griffith, Center for VeterinaryMedicine (HFV-110), Food and Drug Administration, 5600 Fishers Lane, Rockville,MD 20857, 301-443-1963. </ITAG><ITAG tagnum="10"><T2>supplementary information:</T2> Although they are few in number, theremay be new animal drugs that are suspect human carcinogens but that neverthelessmerit approval. Approval of an NADA for such a drug is based in part ona determination that there is virtually no risk of human exposure fromhandling or administration when the drug is used in accordance with labelingdirections.Therefore, CVM has prepared for reviewers of NADA's CVM Staff Manual Guide1240.3140, concerning labeling policy for animal drugs that may be humancarcinogens. The purpose of CVM Staff Manual Guide 1240.3140 is to alertthe reviewers of the need to assure safety to persons using such drugsby preventing human exposure from administration or careless handling.CVM Staff Manual Guide 1240.3140 does not address the issues of human foodsafety or target animal safety.The policy providing for carcinogenesis and human warning statements maybe applied whenever CVM determines there is evidence of carcinogenic activitybased on the criteria included in the CVM Staff Manual Guide 1240.3140.If there is such evidence that a drug is an animal carcinogen, CVM regardsthe drug as a suspect human carcinogen.The following prototype statement should be included in the labels andlabeling of such drugs:``Carcinogenesis:<ITAG tagnum="77">_</ITAG></ITAG><ITAG tagnum="10">(Name of drug) </ITAG><ITAG tagnum="10">has been shown to cause cancer in <ITAG tagnum="77">_</ITAG></ITAG><ITAG tagnum="10">(Species) </ITAG><ITAG tagnum="10">(see human warnings).''CVM Staff Manual Guide 1240.3140 will be used by CVM reviewers followingpublication of this notice in the <T4>Federal Register</T4> as they evaluate pending and future originaland supplemental NADA's submitted for approval. The agency intends to initiatea notice-and-comment rulemaking proceeding to develop a regulation requiringthe statement on the labeling of all previously approved products thatare animal carcinogens as well as on the labeling of all such productsthat are or will be the subject of applications filed with CVM. In themeantime, CVM encourages manufacturers/sponsors of all currently approvedproducts in this category to voluntarily place on product labeling theinformation discussed in CVM Staff Manual Guide 1240.3140. CVM also encouragesmanufacturers/sponsors of all new animal drug products in this categoryfor which applications are or will be pending to submit for its reviewdraft labeling incorporating that information.CVM Staff Manual Guide 1240.3140 is available for public examination inthe Dockets Management Branch (address above) between 9 a.m. and 4 p.m.,Monday through Friday. Requests for single copies of CVM Staff Manual Guide1240.3140 should refer to the docket number found in brackets in the headingof this document and should be submitted to the Dockets Management Branch.<ITAG tagnum="21">Dated: August 31, 1988.</ITAG><ITAG tagnum="6">Frank E. Young,</ITAG><ITAG tagnum="4">Commissioner of Food and Drugs.</ITAG><ITAG tagnum="40">[FR Doc. 88-20914 Filed 9-13-88; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4160-01-M</ITAG></ITAG></ITAG></ITAG></TEXT></DOC>